Clearside Biomedical Stock Investor Sentiment
| CLSD Stock | USD 0.89 0.03 3.49% |
About 80 percent of all Clearside Biomedical's shareholders are aggressively thinking of buying. The analysis of overall sentiment of trading Clearside Biomedical stock suggests that quite a large number of investors are excited at this time. The current market sentiment, together with Clearside Biomedical's historical and current headlines, can help investors time the market. In addition, many technical investors use Clearside Biomedical stock news signals to limit their universe of possible portfolio assets.
Comfort Level 80
Excited
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Clearside Biomedical's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Clearside Biomedical.
News SentimentBullish | Hype SentimentBullish | Insider SentimentAcquiring |
Clearside Historical Sentiment
Although Clearside Biomedical's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Clearside, such as negative comments on social media and news outlets, may cause fear in the market and push Clearside Biomedical's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Clearside.
Clearside |
Clearside Biomedical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Clearside Biomedical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Clearside Biomedical Historical Investor Sentiment
Investor biases related to Clearside Biomedical's public news can be used to forecast risks associated with an investment in Clearside. The trend in average sentiment can be used to explain how an investor holding Clearside can time the market purely based on public headlines and social activities around Clearside Biomedical. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Clearside Biomedical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Clearside Biomedical and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Clearside Biomedical news discussions. The higher the estimate score, the more favorable the investor's outlook on Clearside Biomedical.
Far too much social signal, news, headlines, and media speculation about Clearside Biomedical that are available to investors today. That information is available publicly through Clearside media outlets and privately through word of mouth or via Clearside internal channels. However, regardless of the origin, that massive amount of Clearside data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Clearside Biomedical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Clearside Biomedical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Clearside Biomedical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Clearside Biomedical alpha.
Clearside Biomedical Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye | 12/19/2024 |
2 | Clearside Biomedical Shares Pass Below 50 Day Moving Average - Whats Next - MarketBeat | 12/26/2024 |
3 | Acquisition by Lasezkay George M of 500000 shares of Clearside Biomedical at 0.97 subject to Rule 16b-3 | 01/08/2025 |
4 | Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of ... | 01/22/2025 |
5 | Clearside Biomedical Announces Multiple Medical Meeting Presenta | 01/28/2025 |
6 | Clearside Biomedical to Participate in Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference | 02/04/2025 |
7 | Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY Phase 2b Trial Presented at the Angiogenesis, Exudation, and Degeneration 2025 Meeting | 02/10/2025 |
8 | Acquisition by Yerxa Benjamin R of 7813 shares of Clearside Biomedical at 1.31 subject to Rule 16b-3 | 02/14/2025 |
9 | Clearside Biomedicals Asia-Pacific Partner, Arctic Vision, Anno | 02/20/2025 |
10 | Acquisition by Thorp Clay of 15000 shares of Clearside Biomedical at 0.92 subject to Rule 16b-3 | 02/24/2025 |
11 | Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD | 03/06/2025 |
12 | Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025 | 03/12/2025 |
Complementary Tools for Clearside Stock analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stocks Directory Find actively traded stocks across global markets |